132 results match your criteria: "Hopitaux Universitaires Saint-Louis[Affiliation]"

This paper provides a practical clinical application of guideline recommendations relating to the inpatient monitoring of patients with acute heart failure, through the evaluation of various clinical, biomarker, imaging, invasive and non-invasive approaches. Comprehensive inpatient monitoring is crucial to the optimal management of acute heart failure patients. The European Society of Cardiology heart failure guidelines provide recommendations for the inpatient monitoring of acute heart failure, but the level of evidence underpinning most recommendations is limited.

View Article and Find Full Text PDF

Heart failure is a complex disease process, the manifestation of various cardiac and noncardiac abnormalities. General treatment approaches for heart failure have remained the same over the past decades despite the advent of novel therapies and monitoring modalities. In the same vein, the readmission rates for heart failure patients remain high and portend a poor prognosis for morbidity and mortality.

View Article and Find Full Text PDF

Amoxicillin-tolerant strain isolated from chronic dermohypodermitis after suboptimal exposure to amoxicillin is not associated with reduced growth rate.

J Med Microbiol

April 2018

Service de Médecine Interne, Maladies Infectieuses et Immunologie Clinique, Hôpital Robert Debré, Avenue Général Koenig, 51100 Reims, France.

is rarely observed in human chronic infections. A strain was isolated from a skin biopsy of chronic dermohypodermitis in a 21-year-old woman without an immunocompromised state. As this strain was viable one month after a cat scratch despite treatment by amoxicillin-clavulanic acid, we compared this strain's growth rate, amoxicillin Minimal Inhibitory and Bactericidal Concentrations (MIC and MBC), resistance to serum and ability to activate neutrophil granulocytes with those of control strains isolated during acute infections in humans without previous antibiotics exposure.

View Article and Find Full Text PDF

A Right Insight in Cardiogenic Shock to Get It Right.

J Card Fail

March 2018

U942 INSERM, Assistance Publique-Hôpitaux de Paris, Paris, France; Department of Anesthesia and Critical care. Hôpitaux Universitaires Saint-Louis-Lariboisière, Paris, France; University Paris Diderot, Sorbonne Paris Cité, Paris, France. Electronic address:

View Article and Find Full Text PDF

Determinants of long-term outcome in ICU survivors: results from the FROG-ICU study.

Crit Care

January 2018

Department of Anesthesiology, Critical Care and Burn Unit, Hôpitaux Universitaires Saint Louis-Lariboisière, Assistance Publique-Hôpitaux de Paris, Université Paris Diderot-Paris 7, Sorbonne Paris Cité, UMR-S 942, INSERM, Paris, France.

Background: Intensive care unit (ICU) survivors have reduced long-term survival compared to the general population. Identifying parameters at ICU discharge that are associated with poor long-term outcomes may prove useful in targeting an at-risk population. The main objective of the study was to identify clinical and biological determinants of death in the year following ICU discharge.

View Article and Find Full Text PDF

Effectiveness of guideline-consistent heart failure drug prescriptions at hospital discharge on 1-year mortality: Results from the EPICAL2 cohort study.

Eur J Intern Med

May 2018

Inserm, CHRU Nancy, Université de Lorraine, CIC-1433, Epidémiologie Clinique, F-54000, Nancy, France; Université de Lorraine, EA 4360 Apemac, F-54000, Nancy, France. Electronic address:

Background: We aimed to assess the effectiveness of recommended drug prescriptions at hospital discharge on 1-year mortality in patients with heart failure (HF) and reduced ejection fraction (HFREF).

Materials And Methods: We used data from the EPICAL2 cohort study. HF patients ≥18years old with left ventricular ejection fraction (LVEF) <40% and alive at discharge were included and followed up for mortality.

View Article and Find Full Text PDF

Acute Heart Failure Deserves a Log-Scale Boost in Research Support: Call for Multidisciplinary and Universal Actions.

JACC Heart Fail

January 2018

University Paris Diderot, Paris, France; Pôle de Recherche et D'enseignement Supérieur Sorbonne Paris Cité, Paris, France; INSERM U942, Paris, France; Department of Anesthesiology, Burn and Critical Care Medicine, Hôpitaux Universitaires Saint-Louis-Lariboisière, Assistance Publique-Hôpitaux de Paris, Paris, France. Electronic address:

View Article and Find Full Text PDF
Article Synopsis
  • This study investigates the levels of congestion in patients with acute heart failure (HF), comparing those with preserved ejection fraction (HFpEF) to those with reduced ejection fraction (HFrEF) and non-cardiac dyspnoea.
  • Results show that patients with acute HF exhibit significant signs of congestion, such as larger heart chambers and higher pressures, regardless of ejection fraction status.
  • Both HFpEF and HFrEF patients experienced similar degrees of venous congestion, right ventricular dysfunction, and renal impairment, even though HFrEF patients had higher B-type natriuretic peptide (BNP) levels.
View Article and Find Full Text PDF

In acute heart failure (AHF) syndromes significant respiratory failure (RF) is essentially seen in patients with acute cardiogenic pulmonary oedema (ACPE) or cardiogenic shock (CS). Non-invasive ventilation (NIV), the application of positive intrathoracic pressure through an interface, has shown to be useful in the treatment of moderate to severe RF in several scenarios. There are two main modalities of NIV: continuous positive airway pressure (CPAP) and pressure support ventilation (NIPSV) with positive end expiratory pressure.

View Article and Find Full Text PDF

Friedreich ataxia, an autosomal recessive mitochondrial disease, is the most frequent inherited ataxia. Many studies have attempted to identify cognitive and affective changes associated with the disease, but conflicting results have been obtained, depending on the tests used and because many of the samples studied were very small. We investigated personality and neuropsychological characteristics in a cohort of 47 patients with genetically confirmed disease.

View Article and Find Full Text PDF

Objectives: Mycobacterium chimaera is a recently described nontuberculous mycobacterium belonging to the Mycobacterium avium complex (MAC). Because this species is implicated in a worldwide outbreak due to contaminated heater-cooler unit water tanks during open-heart surgery, it has become mandatory for clinical microbiology laboratories to be able to differentiate M. chimaera from the other MAC species, especially M.

View Article and Find Full Text PDF

Molecular detection methods of resistance to antituberculosis drugs in Mycobacterium tuberculosis.

Med Mal Infect

September 2017

Inserm Sorbonne universités, UPMC université Paris 06, CR7, U1135, centre d'immunologie et des maladies infectieuses, CIMI, Team E13 (bactériologie), 91, boulevard de l'hôpital, 75013 Paris, France; Centre national de référence des mycobactéries et de la résistance des mycobactéries aux antituberculeux (CNR-MyRMA), bactériologie-hygiène, hôpitaux universitaires Pitié-Salpêtrière-Charles-Foix, AP-HP, 47-83, boulevard de l'hôpital, 75013 Paris, France; Hôpitaux universitaires Saint-Louis-Lariboisière, AP-HP, 2, rue Ambroise-Paré, 75010 Paris, France.

Objective: Molecular methods predict drug resistance several weeks before phenotypic methods and enable rapid implementation of appropriate therapeutic treatment. We aimed to detail the most representative molecular tools used in routine practice for the rapid detection of resistance to antituberculosis drugs among Mycobacterium tuberculosis strains.

Materials And Methods: The molecular diagnosis of resistance to antituberculosis drugs in clinical samples or from in vitro cultures is based on the detection of the most common mutations in the genes involved in the development of resistance in M.

View Article and Find Full Text PDF

Introduction: During general anesthesia, arterial hypotension is frequent and may be an important contributor to perioperative morbidity. We assessed the effect of a 5 μg bolus of Norepinephrine (NA) when compared with 50 μg bolus of Phenylephrine (PE) administered to treat hypotension during maintenance anesthesia, on MAP, derived cardiac output and arterial stiffness parameters.

Methods: Patients scheduled for a neurosurgical procedure under general anesthesia were prospectively included.

View Article and Find Full Text PDF

[How I do… to perform uterine adenomyomectomy].

Gynecol Obstet Fertil Senol

May 2017

Service de gynécologie obstétrique, hôpital Lariboisière, hôpitaux universitaires Saint-Louis-Lariboisière-Fernand-Widal, faculté de médecine Paris VII Diderot, 2, rue Ambroise-Paré, 75475 Paris cedex 10, France.

View Article and Find Full Text PDF

Aims: To identify differences in clinical epidemiology, in-hospital management and 1-year outcomes among patients hospitalized for acute heart failure (AHF) and enrolled in the European Society of Cardiology Heart Failure Long-Term (ESC-HF-LT) Registry, stratified by clinical profile at admission.

Methods And Results: The ESC-HF-LT Registry is a prospective, observational study collecting hospitalization and 1-year follow-up data from 6629 AHF patients. Among AHF patients enrolled in the registry, 13.

View Article and Find Full Text PDF

Background: Dyspnea is the most common presenting symptom in patients with acute heart failure (AHF), but is difficult to quantify as a research measure. The URGENT Dyspnea study compared 3 scales: (1) 10 cm VAS, (2) 5-point Likert, and (3) a 7-point Likert (both VAS and 5-point Likert were recorded in the upright and supine positions). However, the minimal clinically important difference (MCID) to patients has not been well established.

View Article and Find Full Text PDF

Although cardiovascular disease is a major health burden for patients with chronic kidney disease, most cardiovascular outcome trials have excluded patients with advanced chronic kidney disease. Moreover, the major cardiovascular outcome trials that have been conducted in patients with end-stage renal disease have not demonstrated a treatment benefit. Thus, clinicians have limited evidence to guide the management of cardiovascular disease in patients with chronic kidney disease, particularly those on dialysis.

View Article and Find Full Text PDF